{"slug":"tesamorelin-glp1-gut","verification":{"valid":true,"entries":6,"head":"f94078a23f3c1f4419fa25cb974382c7a8eae278450cab261f0a2a3e2843118c"},"count":6,"sources":[{"id":"s18","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/25038357/","title":"Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation","quote":"Tesamorelin administered for 6 months was associated with reductions in visceral fat and additionally with modest reductions in liver fat.","summary":"Randomized trial showing VAT and liver fat reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"572067c3fce83b6749fc4ce3704cb3e3aff876c65beedb8f911bbe4cc70e16c0"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/17646624/","title":"Metabolic Effects of a Growth Hormone–Releasing Factor Analog","quote":"Daily tesamorelin for 26 weeks decreased visceral fat and improved lipid profiles","summary":"Phase 3 trial results on visceral fat reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"unverified","prev":"572067c3fce83b6749fc4ce3704cb3e3aff876c65beedb8f911bbe4cc70e16c0","hash":"41f8a570f313a50f40f9be20405250048f480915bba10bbfb29f36cb36979d7b"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2693693/","title":"Gastric motor effects of ghrelin and growth hormone releasing peptide-6 in diabetic mice with gastroparesis","quote":"Ghrelin and GHRP-6 increase gastric emptying in diabetic mice with gastroparesis","summary":"Preclinical motility study.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"verified","prev":"41f8a570f313a50f40f9be20405250048f480915bba10bbfb29f36cb36979d7b","hash":"3c6539dcb376d56418f00fef05c9a6086b10dbbc517f698e925b2b327ceffafa"},{"id":"s12","type":"pubmed","url":"https://gi.org/journals-publications/ebgi/phil_paul_nov2023/","title":"GI Adverse Events with GLP-1 Agonists for Weight Loss","quote":"Incidence rates for ... gastroparesis (aHR 3.7, 95% CI 1.2-11.9) were significantly higher among users of GLP-1 receptor agonists","summary":"Observational risk data.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"unverified","prev":"3c6539dcb376d56418f00fef05c9a6086b10dbbc517f698e925b2b327ceffafa","hash":"b8a6ed4234ee75097b033c57f8856127e6bf8da1535be72c1859a4db235585c9"},{"id":"s0","type":"other","url":"https://www.yoodirecthealth.com/blog/peptides-for-body-composition-tesamorelin-and-beyond/","title":"Tesamorelin Peptide: How It Targets Stubborn Belly Fat","quote":"GLP-1 medications reduce appetite and slow gastric emptying. Tesamorelin works upstream by improving growth hormone signaling","summary":"Compares mechanisms, notes no gastric slowing from Tesamorelin.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"unverified","prev":"b8a6ed4234ee75097b033c57f8856127e6bf8da1535be72c1859a4db235585c9","hash":"b42068337113c083e81fef4564b8f258d348f6b37c048e7b1730d8b68da47829"},{"id":"s8","type":"other","url":"https://peptides359.com/tesamorelin-delayed-gastric-emptying-alcoholfree/","title":"tesamorelin delayed gastric emptying","quote":"Current research clarifies that tesamorelin itself does not directly cause delayed gastric emptying.","summary":"Notes distinction from GLP-1 effects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:45.268Z","link_status":"ok","quote_status":"unverified","prev":"b42068337113c083e81fef4564b8f258d348f6b37c048e7b1730d8b68da47829","hash":"f94078a23f3c1f4419fa25cb974382c7a8eae278450cab261f0a2a3e2843118c"}]}